Inventor
BEUSKER PATRICK HENRY
NL14 patents
⚠️ This page may combine multiple inventors who share the name “BEUSKER PATRICK HENRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNTARGA BV
5 patentsUS7223837B2May 29, 2007
Elongated and multiple spacers in activatible prodrugs
SYNTARGA BV237 citations92
US7705045B2Apr 27, 2010
Prodrugs built as multiple self-elimination-release spacers
SYNTARGA BV47 citations91
US9815784B2Nov 14, 2017
CC-1065 analogs and their conjugates
SYNTARGA BV7 citations81
US9901567B2Feb 27, 2018
Substituted CC-1065 analogs and their conjugates
SYNTARGA BV4 citations70
US11052155B2Jul 6, 2021
Conjugates of CC-1065 analogs and bifunctional linkers
SYNTARGA BV0 citations59
BEUSKER PATRICK HENRY
5 patentsUS8158590B2Apr 17, 2012
Triazole-containing releasable linkers, conjugates thereof, and methods of preparation
BEUSKER PATRICK HENRY7 citations82
US8680293B2Mar 25, 2014
Substituted CC-1065 analogs and their conjugates
BEUSKER PATRICK HENRY16 citations81
US9629924B2Apr 25, 2017
Conjugates of CC-1065 analogs and bifunctional linkers
BEUSKER PATRICK HENRY6 citations80
US8889868B2Nov 18, 2014
CC-1065 analogs and their conjugates
BEUSKER PATRICK HENRY14 citations79
US8940784B2Jan 27, 2015
Water-soluble CC-1065 analogs and their conjugates
BEUSKER PATRICK HENRY3 citations56
SYNTHON BIOPHARMACEUTICALS BV
3 patentsUS9421278B2Aug 23, 2016
Duocarmycin ADCS showing improved in vivo antitumor activity
SYNTHON BIOPHARMACEUTICALS BV14 citations88
US9890159B2Feb 13, 2018
Process for making duocarmycin prodrugs
SYNTHON BIOPHARMACEUTICALS BV4 citations68
US10603387B2Mar 31, 2020
Duocarmycin ADCs showing improved in vivo antitumor activity
SYNTHON BIOPHARMACEUTICALS BV0 citations47